|
NSD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81239999569516E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16559999827371E-08 |
| Normal-vs-Stage2 |
3.218800E-04 |
| Normal-vs-Stage3 |
8.230900E-04 |
| Normal-vs-Stage4 |
5.650400E-02 |
| Stage1-vs-Stage2 |
9.168400E-01 |
| Stage1-vs-Stage3 |
9.187000E-01 |
| Stage1-vs-Stage4 |
7.697200E-01 |
| Stage2-vs-Stage3 |
8.771800E-01 |
| Stage2-vs-Stage4 |
7.676200E-01 |
| Stage3-vs-Stage4 |
8.620400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93379999791077E-08 |
| Normal-vs-AfricanAmerican |
7.57940000000179E-05 |
| Normal-vs-Asian |
3.180800E-04 |
| Caucasian-vs-AfricanAmerican |
4.086000E-01 |
| Caucasian-vs-Asian |
5.387000E-01 |
| AfricanAmerican-vs-Asian |
3.495200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00210004130952E-09 |
| Normal-vs-Female |
7.361900E-03 |
| Male-vs-Female |
1.626000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.950070E-04 |
| Normal-vs-Extreme_Weight |
5.21970000555427E-09 |
| Normal-vs-Obese |
6.37219999999328E-05 |
| Normal-vs-Extreme_Obese |
9.96290000000455E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.039800E-01 |
| Normal_Weight-vs-Obese |
5.611400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.735400E-01 |
| Extreme_Weight-vs-Obese |
8.526100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.869000E-01 |
| Obese-vs-Extreme_Obese |
3.755800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.19589999997483E-06 |
| Normal-vs-Age(41-60Yrs) |
1.142130E-03 |
| Normal-vs-Age(61-80Yrs) |
2.45339970561531E-10 |
| Normal-vs-Age(81-100Yrs) |
2.97399999960035E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.677500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.362800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.128800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.985900E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.623800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.782800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.54609999750244E-08 |
| Normal-VS-Type2 PRCC |
2.04120000013575E-07 |
| Normal-VS-KIRP CIMP |
3.30350002908375E-09 |
| Normal-VS-Unclassified PRCC |
2.621200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.993200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.859400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.505700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.009500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.578300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.84659999999637E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15049969551251E-10 |
| Normal-vs-N1 |
8.520200E-03 |
| Normal-vs-N2 |
1.391540E-04 |
| N0-vs-N1 |
2.861200E-01 |
| N0-vs-N2 |
2.758400E-01 |
| N1-vs-N2 |
3.028600E-01 |
|
|
